Dr. Chavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Water St
Cambridge, MA 02141
Summary
- Dr. Jeffrey Chavin is a neurologist in Cambridge, MA. He received his medical degree from Temple University School of Medicine and has been in practice 27 years. He specializes in neuroimmunology/multiple sclerosis and neuromuscular medicine and is experienced in neuromuscular medicine, neuroimmunology (multiple sclerosis), and muscular dystrophy.
Education & Training
- Tufts Medical CenterResidency, Neurology, 1995 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1992 - 1995
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1991 - 1992
- Lewis Katz School of Medicine at Temple UniversityClass of 1990
Certifications & Licensure
- MA State Medical License 1995 - 2026
- PA State Medical License 1993 - 1995
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 3 citationsEffectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis.Regina Berkovich, Donald Negroski, Daniel Wynn, Daniel Sellers, Kristen G Bzdek
Multiple Sclerosis and Related Disorders. 2023-02-01 - 8 citationsVaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide.Carlo Tornatore, Heinz Wiendl, Alex L Lublin, Svend S Geertsen, Jeffrey Chavin
Frontiers in Neurology. 2022-01-01 - 6 citationsEffect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease.Yoshimi Enose-Akahata, Nyater Ngouth, Joan Ohayon, Matt Mandel, Jeffrey Chavin
Neurology(R) Neuroimmunology & Neuroinflammation. 2021-04-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: